SCHEMBL17475801

SCHEMBL17475801

CC(CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.34
CYP11B1 P15538 2/20 0.34
ALK Q9UM73 9/20 0.34
ITK Q08881 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OGFRL1 Q5TC84 1/20 0.33
INSR P06213 2/20 0.32
LCK P06239 2/20 0.32
LTK P29376 2/20 0.32
AXL P30530 2/20 0.32
IRAK1 P51617 2/20 0.32
MAP4K2 Q12851 2/20 0.32
MERTK Q12866 2/20 0.32
NTRK1 P04629 1/20 0.32
FLT3 P36888 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
P2RX7 Q99572 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16084407 1.00 CYP11B2 (0.34) CYP11B2CYP11B1ALKITKOPRM1
SCHEMBL16084295 1.00 CYP11B2 (0.34) CYP11B2CYP11B1ALKITKOPRM1
SCHEMBL17481404 0.90 ALK (0.34) ALKOPRM1OPRD1OGFRL1INSR
SCHEMBL17481405 0.90 ALK (0.34) ALKOPRM1OPRD1OGFRL1INSR
SCHEMBL16084218 0.87 CYP11B2 (0.38) CYP11B2CYP11B1OPRM1OPRD1OGFRL1
SCHEMBL17475780 0.87 ALK (0.34) ALKINSRLCKLTKAXL
SCHEMBL16084412 0.87 ALK (0.34) ALKINSRLCKLTKAXL
SCHEMBL16084406 0.87 ALK (0.34) ALKINSRLCKLTKAXL
SCHEMBL16084346 0.87 CYP11B2 (0.34) CYP11B2CYP11B1ALKOPRM1OPRD1
SCHEMBL21375485 0.86 CYP11B2 (0.38) CYP11B2CYP11B1ALKOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970277-B1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KNOPP BIOSCIENCES LLC (US) 2021-07-28 EP disclosed
US-20190002464-A1 IMIDAZO[4,5-B]PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS CHANNEL BIOSCIENCES, LLC 2019-01-03 US disclosed
US-10106536-B2 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators KNOPP BIOSCIENCES LLC (US) 2018-10-23 US disclosed
US-20170240547-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS CHANNEL BIOSCIENCES, LLC 2017-08-24 US disclosed
US-9650376-B2 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators KNOPP BIOSCIENCES LLC (US) 2017-05-16 US disclosed
US-20160031875-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS CHANNEL BIOSCIENCES, LLC 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10106536-B2 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators KCNA7, KCNA2, KCNK17 CYP11B2 1933/4885CYP11B1 1968/4885ALK 1876/4885
US-20160031875-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KCNA7, KCNA2, KCNK17 CYP11B2 1933/4885CYP11B1 1968/4885ALK 1876/4885
US-20190002464-A1 IMIDAZO[4,5-B]PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KCNA7, KCNA2, KCNK17 CYP11B2 2067/4885CYP11B1 2093/4885ALK 1757/4885
US-20170240547-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KCNA7, KCNA2, KCNK17 CYP11B2 1933/4885CYP11B1 1968/4885ALK 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.